Skip to main content
Premium Trial:

Request an Annual Quote

JCVI to Use Pressure Bio's Sample Prep Technology in Microbiome Study

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has entered into a collaboration with the J. Craig Venter Institute, under which JVCI has purchased one of the firm’s Barocycler NEP2320 PCT Sample Preparation Systems.
 
JVCI will use the system, which incorporates the firm’s pressure cycling technology, for its research as part of the NIH-funded Human Microbiome Project. Pressure Bio also intends to provide JCVI with two more instruments for additional studies as part of the collaboration.
 
In addition to using the instruments, JCVI will further develop the pressure cycling technology into its extraction protocols.
 
The technology is used for extracting nucleic acids and proteins from samples, and Scott Peterson, director of functional genomics research and technology at JCVI, said that it has “the unique ability to extract higher molecular weight DNA for further sequence analysis of the organisms we work with here at JCVI.”
 
South Easton, Mass.-based Pressure Bio also said that it has sold two PCT Sample Preparation Systems to an unnamed global pharmaceutical company.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more